Trial Outcomes & Findings for Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy (NCT NCT03380572)
NCT ID: NCT03380572
Last Updated: 2019-05-21
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
40 participants
Primary outcome timeframe
1 day
Results posted on
2019-05-21
Participant Flow
Participant milestones
| Measure |
Senhance Cholecystectomy
Cholecystectomy operation performed using Senhance robotic system
Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
|
Laparoscopic Cholecystectomy
Cholecystectomy operation performed using standard laparoscopic instruments
Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
20
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Senhance Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using Senhance robotic system
Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
|
Laparoscopic Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using standard laparoscopic instruments
Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
45.9 years
STANDARD_DEVIATION 13 • n=20 Participants
|
48.4 years
STANDARD_DEVIATION 12.2 • n=20 Participants
|
46 years
STANDARD_DEVIATION 12 • n=40 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=20 Participants
|
17 Participants
n=20 Participants
|
34 Participants
n=40 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=20 Participants
|
3 Participants
n=20 Participants
|
6 Participants
n=40 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United Kingdom
|
20 participants
n=20 Participants
|
20 participants
n=20 Participants
|
40 participants
n=40 Participants
|
PRIMARY outcome
Timeframe: 1 dayOutcome measures
| Measure |
Senhance Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using Senhance robotic system
Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
|
Laparoscopic Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using standard laparoscopic instruments
Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
|
|---|---|---|
|
Operative Time
|
86.5 minutes
Interval 60.5 to 106.5
|
31.5 minutes
Interval 26.0 to 41.0
|
SECONDARY outcome
Timeframe: 30 daysOutcome measures
| Measure |
Senhance Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using Senhance robotic system
Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
|
Laparoscopic Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using standard laparoscopic instruments
Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
|
|---|---|---|
|
Morbidity Data
|
3 Participants
|
5 Participants
|
Adverse Events
Senhance Cholecystectomy
Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths
Laparoscopic Cholecystectomy
Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Senhance Cholecystectomy
n=20 participants at risk
Cholecystectomy operation performed using Senhance robotic system
Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
|
Laparoscopic Cholecystectomy
n=20 participants at risk
Cholecystectomy operation performed using standard laparoscopic instruments
Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
|
|---|---|---|
|
Skin and subcutaneous tissue disorders
Wound infection
|
5.0%
1/20 • Number of events 1 • 30 days
|
15.0%
3/20 • Number of events 3 • 30 days
|
|
Hepatobiliary disorders
Bile leak
|
0.00%
0/20 • 30 days
|
5.0%
1/20 • Number of events 1 • 30 days
|
|
Blood and lymphatic system disorders
Bleeding
|
5.0%
1/20 • Number of events 1 • 30 days
|
0.00%
0/20 • 30 days
|
|
General disorders
Pain
|
5.0%
1/20 • Number of events 1 • 30 days
|
5.0%
1/20 • Number of events 1 • 30 days
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place